siRNA treatment lowers triglycerides in people along with rare disorder

.ANALYSIS FEATURE.19 September 2024.

Plozasiran minimized triglyceride levels through 80% and decreased the danger of pancreatitis in patients with persistent chylomicronemia, along with or even without a hereditary diagnosis.